480 related articles for article (PubMed ID: 9525341)
1. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
Mercer B; Markland F; Minkin C
J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
[TBL] [Abstract][Full Text] [Related]
2. Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis.
Trikha M; De Clerck YA; Markland FS
Cancer Res; 1994 Sep; 54(18):4993-8. PubMed ID: 7520832
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat.
Lark MW; Stroup GB; Dodds RA; Kapadia R; Hoffman SJ; Hwang SM; James IE; Lechowska B; Liang X; Rieman DJ; Salyers KL; Ward K; Smith BR; Miller WH; Huffman WF; Gowen M
J Bone Miner Res; 2001 Feb; 16(2):319-27. PubMed ID: 11204432
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
Xue W; Mizukami I; Todd RF; Petty HR
Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom.
Zhou Q; Hu P; Ritter MR; Swenson SD; Argounova S; Epstein AL; Markland FS
Arch Biochem Biophys; 2000 Mar; 375(2):278-88. PubMed ID: 10700384
[TBL] [Abstract][Full Text] [Related]
6. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
Lark MW; Stroup GB; Hwang SM; James IE; Rieman DJ; Drake FH; Bradbeer JN; Mathur A; Erhard KF; Newlander KA; Ross ST; Salyers KL; Smith BR; Miller WH; Huffman WF; Gowen M
J Pharmacol Exp Ther; 1999 Nov; 291(2):612-7. PubMed ID: 10525079
[TBL] [Abstract][Full Text] [Related]
7. Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5.
Zhou Q; Nakada MT; Brooks PC; Swenson SD; Ritter MR; Argounova S; Arnold C; Markland FS
Biochem Biophys Res Commun; 2000 Jan; 267(1):350-5. PubMed ID: 10623623
[TBL] [Abstract][Full Text] [Related]
8. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH
J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185
[TBL] [Abstract][Full Text] [Related]
9. Integrin function in osteoclasts.
Rodan SB; Rodan GA
J Endocrinol; 1997 Sep; 154 Suppl():S47-56. PubMed ID: 9379137
[TBL] [Abstract][Full Text] [Related]
10. Contortrostatin, a snake venom disintegrin, induces alphavbeta3-mediated tyrosine phosphorylation of CAS and FAK in tumor cells.
Ritter MR; Zhou Q; Markland FS
J Cell Biochem; 2000 Jul; 79(1):28-37. PubMed ID: 10906753
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
[TBL] [Abstract][Full Text] [Related]
12. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells.
Sheu JR; Lin CH; Peng HC; Huang TF
Proc Soc Exp Biol Med; 1996 Oct; 213(1):71-9. PubMed ID: 8820826
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
[TBL] [Abstract][Full Text] [Related]
14. Integrin subunit beta3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface.
Holt I; Marshall MJ
J Cell Physiol; 1998 Apr; 175(1):1-9. PubMed ID: 9491775
[TBL] [Abstract][Full Text] [Related]
15. Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion.
Sánchez EE; Rodríguez-Acosta A; Palomar R; Lucena SE; Bashir S; Soto JG; Pérez JC
Arch Toxicol; 2009 Mar; 83(3):271-9. PubMed ID: 18830584
[TBL] [Abstract][Full Text] [Related]
16. Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat.
Crippes BA; Engleman VW; Settle SL; Delarco J; Ornberg RL; Helfrich MH; Horton MA; Nickols GA
Endocrinology; 1996 Mar; 137(3):918-24. PubMed ID: 8603604
[TBL] [Abstract][Full Text] [Related]
17. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model.
Beviglia L; Stewart GJ; Niewiarowski S
Oncol Res; 1995; 7(1):7-20. PubMed ID: 7549046
[TBL] [Abstract][Full Text] [Related]
18. The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2beta1 integrin-mediated cell adhesion.
Souza DH; Iemma MR; Ferreira LL; Faria JP; Oliva ML; Zingali RB; Niewiarowski S; Selistre-de-Araujo HS
Arch Biochem Biophys; 2000 Dec; 384(2):341-50. PubMed ID: 11368322
[TBL] [Abstract][Full Text] [Related]
19. Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells.
Nakamura I; Tanaka H; Rodan GA; Duong LT
Endocrinology; 1998 Dec; 139(12):5182-93. PubMed ID: 9832459
[TBL] [Abstract][Full Text] [Related]
20. The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats.
Yamamoto M; Fisher JE; Gentile M; Seedor JG; Leu CT; Rodan SB; Rodan GA
Endocrinology; 1998 Mar; 139(3):1411-9. PubMed ID: 9492078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
